| Value | ₹0.78 Cr |
|---|---|
| Execution period | 3 years vesting; 5 years exercise |
NSE filing, NSE: RBLBANK. Summary written from the filing by ALFA Finder's alert engine.
RBL Bank Ltd: key numbers
- Share price
- ₹349.95
- Market cap
- ₹54,322 Cr
- Revenue (annual)
- ₹14,337 Cr
- Net profit (annual)
- ₹879.0 Cr
- P/E (TTM)
- 45.1×Sector 19.7×
- Promoter holding
- 59.88%-0.12% QoQ
- FII holding
- 8.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RBL Bank Ltd
All →RBL Bank Annual General Meeting
RBL Bank seeks shareholder approval via postal ballot for remuneration of its MD & CEO, an Executive Director and a retired ED. Voting runs October 28 to November 26, 2026.
RBL Bank Employee Stock Options
RBL Bank allotted 5,28,745 ESOP shares to employees following exercise of vested options on October 26, 2026. Paid-up capital rose to 155.28 crore shares.
RBL Bank Regulatory Approval
RBL Bank has received RBI approval for the amalgamation of Emirates NBD Bank's Indian branches. The integration is effective from December 01, 2026.
RBL Bank Earnings Call Transcript: Key Takeaways
Strong balance sheet expansion driven by one-time FCNR(B) deposits and equity capital.
RBL Bank Management Change
RBL Bank announced the appointment of Mr. Ashwini Kumar Choudhary as Chief Risk Officer and the re-appointment of Mr. Prakash Gupta as Chief Compliance Officer.
RBL Bank Investor Presentation: Key Takeaways
RBL Bank reports strong Q2 FY27 performance with Net Profit surging 170% YoY to ₹4.82 bn. Growth driven by 37% NII expansion and significant improvement in asset quality.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date